1. Home
  2. WVE vs SPNT Comparison

WVE vs SPNT Comparison

Compare WVE & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.25

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo SiriusPoint Ltd.

SPNT

SiriusPoint Ltd.

HOLD

Current Price

$23.26

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
SPNT
Founded
2012
2011
Country
Singapore
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
SPNT
Price
$7.25
$23.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
2
Target Price
$29.50
$27.50
AVG Volume (30 Days)
6.4M
659.8K
Earning Date
04-28-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
$0.85
Revenue Next Year
$85.67
$5.85
P/E Ratio
N/A
$5.65
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$16.07
52 Week High
$21.73
$23.66

Technical Indicators

Market Signals
Indicator
WVE
SPNT
Relative Strength Index (RSI) 34.60 63.90
Support Level $6.93 $19.45
Resistance Level $7.67 $23.42
Average True Range (ATR) 0.33 0.52
MACD 0.23 0.04
Stochastic Oscillator 47.80 75.00

Price Performance

Historical Comparison
WVE
SPNT

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About SPNT SiriusPoint Ltd.

SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.

Share on Social Networks: